Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Brain Neurotherapy Bio, Inc.

Clinical trials sponsored by Brain Neurotherapy Bio, Inc., explained in plain language.

Not yet finished but already full! 1

Experimental gene therapy tested for rare brain disease

Disease control Ongoing

This early-stage study tests whether a gene therapy called AAV2-GDNF is safe for people with multiple system atrophy (MSA), a rare and serious brain disorder. Nine adults aged 35-75 with MSA will receive either the gene therapy or a placebo. The main goal is to check for side eff…

Phase: PHASE1 • Sponsor: Brain Neurotherapy Bio, Inc. • Aim: Disease control

Last updated May 20, 2026 11:56 UTC